Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

260

LikeLikedUnlike

211-225 of 347

Breastfeeding with MS: Monoclonal Antibodies May Not Impact Child Development
NeuroFrontiers
Breastfeeding with MS: Monoclonal Antibodies May Not Impact Child Development
Exploring the Clinical Treatments of Schizophrenia
NeuroFrontiers
Exploring the Clinical Treatments of Schizophrenia
- Ashley Baker, MSN, PMHNP
  Peer
- Nabil Ali, MD
  Peer
The Role of Occupational Therapy in Schizophrenia Management
NeuroFrontiers
The Role of Occupational Therapy in Schizophrenia Management
- Ashley Baker, MSN, PMHNP
  Peer
- Lauren Walker, OT
  Peer
Investigating the Prevalence of Comorbidities in MS Clinical Trials
NeuroFrontiers
Investigating the Prevalence of Comorbidities in MS Clinical Trials
- Ashley Baker, MSN, PMHNP
  Peer
- Amber Salter, PhD
  Peer
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
NeuroFrontiers
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Victoria Leavitt, PhD
  Peer
Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
NeuroFrontiers
Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Dejan Jakimovski, MD, PhD
  Peer
advertisement
The Alarming Shortage of ADHD Medication and Its Implications on Patients
NeuroFrontiers
The Alarming Shortage of ADHD Medication and Its Implications on Patients
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
NeuroFrontiers
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
- Ashley Baker, MSN, PMHNP
  Peer
- Samuel Dienel, PhD
  Peer
Practices for Preventing Polypharmacy in Multiple Sclerosis
NeuroFrontiers
Practices for Preventing Polypharmacy in Multiple Sclerosis
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Ahmed Z. Obeidat, MD, PhD
  Peer
- Lauren Beranek, BS
  Peer
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
NeuroFrontiers
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
- Ashley Baker, MSN, PMHNP
  Peer
- Stanley N. Caroff, MD
  Peer
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiers
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jagan Pillai, MD, PhD
  Peer
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiers
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
advertisement
Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiers
Exploring the Latest in MS Cognitive Rehabilitation Strategies
- Nancy Chiaravalloti, PhD
  Peer
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
NeuroFrontiers
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
- Daniel Harrison, MD
  Peer
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
NeuroFrontiers
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
- Ashley Baker, MSN, PMHNP
  Peer
- Anna A. Shah, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended